← All companies
DMII
Drugs Made In America Acquisition II Corp.
$10.11
-0.01 -0.10%
Key statistics
from XBRL data in SEC filingsMarket cap
$644M
Revenue (TTM)
—
Net income (TTM)
$8.58M
EPS (TTM)
—
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$348K
Total assets
$510M
Gross margin
—
52-week range
$9.86 – $10.20
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-03-31
May 14, 2026
8-K
Entered a material agreement
Apr 28, 2026
10-K
Fiscal year ended 2025-12-31
Apr 15, 2026
8-K
Entered a material agreement; Took on a direct financial obligation
Apr 3, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Other events
Mar 17, 2026
8-K
Other events
Mar 6, 2026
8-K
Director or officer change
Mar 6, 2026
10-Q
Quarter ended 2025-09-30
Nov 18, 2025
8-K
Director or officer change
Nov 18, 2025
8-K
Other events
Oct 2, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Other events
Sep 29, 2025
Other filings
NT 10-K
NOTIFICATION OF LATE FILING
Apr 1, 2026
NT 10-Q
NOTIFICATION OF LATE FILING
Nov 17, 2025
4
Oct 17, 2025
4
Oct 2, 2025
SCHEDULE 13D
Oct 2, 2025
4
Oct 1, 2025
4
Oct 1, 2025
4
Oct 1, 2025
4
Oct 1, 2025
3
Sep 25, 2025
424B4
PROSPECTUS SUPPLEMENT
Sep 25, 2025
EFFECT
Sep 24, 2025
3
Sep 24, 2025
3
Sep 24, 2025
3
Sep 24, 2025
3
Sep 24, 2025
3
Sep 24, 2025
CERT
Sep 24, 2025
8-A12B
FOR REGISTRATION OF CERTAIN CLASSES
Sep 24, 2025
CORRESP
Sep 22, 2025
CORRESP
Sep 22, 2025
CORRESP
Sep 16, 2025
S-1/A
REGISTRATION STATEMENT
Sep 16, 2025
UPLOAD
Sep 15, 2025
S-1/A
REGISTRATION STATEMENT
Sep 15, 2025
S-1/A
REGISTRATION STATEMENT
Sep 5, 2025
S-1
REGISTRATION STATEMENT
Jul 21, 2025
CORRESP
Jul 18, 2025
UPLOAD
May 2, 2025